Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Terns Pharmaceuticals Inc (NASDAQ: TERN) closed at $8.33 down -7.55% from its previous closing price of $9.01. In other words, the price has decreased by -$7.55 from its previous closing price. On the day, 0.94 million shares were traded. TERN stock price reached its highest trading level at $9.04 during the session, while it also had its lowest trading level at $8.25.
Ratios:
For a deeper understanding of Terns Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 27.85 and its Current Ratio is at 27.85. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on June 22, 2023, initiated with a Buy rating and assigned the stock a target price of $16.
On June 07, 2023, Jefferies started tracking the stock assigning a Buy rating and target price of $18.
On May 31, 2023, ROTH MKM started tracking the stock assigning a Buy rating and target price of $23.ROTH MKM initiated its Buy rating on May 31, 2023, with a $23 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 16 ’24 when ORBIMED ADVISORS LLC sold 5,188 shares for $10.00 per share. The transaction valued at 51,880 led to the insider holds 755,635 shares of the business.
GORDON CARL L sold 5,188 shares of TERN for $51,880 on Jul 16 ’24. The Director now owns 755,635 shares after completing the transaction at $10.00 per share. On Jul 16 ’24, another insider, Quigley Jill M., who serves as the Director of the company, sold 400 shares for $10.00 each. As a result, the insider received 4,000 and left with 30,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TERN now has a Market Capitalization of 538760256 and an Enterprise Value of 298533632.
Stock Price History:
Over the past 52 weeks, TERN has reached a high of $10.03, while it has fallen to a 52-week low of $3.26. The 50-Day Moving Average of the stock is 13.20%, while the 200-Day Moving Average is calculated to be 34.39%.
Shares Statistics:
For the past three months, TERN has traded an average of 1.19M shares per day and 1139970 over the past ten days. A total of 64.58M shares are outstanding, with a floating share count of 43.10M. Insiders hold about 33.37% of the company’s shares, while institutions hold 76.55% stake in the company. Shares short for TERN as of 1721001600 were 1993709 with a Short Ratio of 1.68, compared to 1718323200 on 2296762. Therefore, it implies a Short% of Shares Outstanding of 1993709 and a Short% of Float of 3.5000000000000004.
